PhRMA code has mixed effect on forces

Recent changes to the PhRMA code are not having a tremendous impact on sales reps' ability to sell target physicians on the merits of their companies' brands, according to the results of a survey from Durham, NC-based Cutting Edge Information.

On a scale from 1 to 10, with 10 being a tremendous hindrance to sales efforts and 1 being no effect on sales efforts, companies rated the PhRMA changes as a 5.5 on average. While the overall results indicate that the code changes have not drastically impacted sales reps' ability to access physicians, individual companies are reporting significant impact from the revisions, according to Cutting Edge's survey.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.